Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Oxurion NV, a biopharmaceutical company based in Leuven, Belgium, received several transparency notifications from Atlas Special Opportunities II LLC. On August 28, 2025, it was revealed that Atlas had exceeded the 15% ownership threshold on July 28, holding 7,338,549 shares out of 36,983,581. Successive sales and purchases subsequently changed this ownership. Notably, on July 31, Atlas owned 15,462,701 shares, exceeding the 30% threshold with 50,377,523 shares outstanding. From August 1, Atlas's ownership decreased, falling below various thresholds due to sales until August 15, when it stood at 6,677,305 shares.